A new blood test can detect lung cancer in real time, enabling earlier diagnosis, quicker treatment, reduced delays, and improved survival outcomes for patients.

The nine minor health issues that could be early signs of lung cancer - As the NHS offers a ‘revolutionary’ blood test, here ...

Lung cancer accounts for 1 in 5 cancer-related deaths in the United States. While doctors say lung cancer is often treatable if caught early, millions of Americans who should be getting screened for ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored. The research team—which brings together academics from University Hospitals of ...

A new way of diagnosing lung cancer with a blood draw is 10 times faster and 14 times more sensitive than earlier methods, according to University of Michigan researchers. The microchip developed at U ...

A new way of diagnosing lung cancer with a blood draw is 10 times faster and 14 times more sensitive than earlier methods, according to researchers. A new way of diagnosing lung cancer with a blood ...

ROSTRAVER TOWNSHIP, Pa. — Cancer is a disease that has touched most families in some capacity. The one that kills the most people annually is lung cancer. The reason why is most people don’t get ...

Blood clots form in response to signals from the lungs of cancer patients -- not from other organ sites, as previously thought -- according to a preclinical study. Clots are the second-leading cause ...

Certain lung cancer patients might notice swollen fingers and nails, alongside joint pain and inflammation. This ailment is ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...